ASXL1 plays a role in the increased production of malignant neutrophils in CNL patients with CSF3R mutations by repressing the production of MYC transcripts, which normally would lead to decreased myeloid differentiation [51]. This evidence concerns the gene ASXL1 and chronic neutrophilic leukemia.